FDA Approved: GA-68-DOTATOC — Supplemental Application (UIHC P E T Imaging Center)

View source ↗

Summary

FDA approved a supplemental application for GA-68-DOTATOC (edotreotide gallium-68) for PET imaging, enabling its use in neuroendocrine tumor imaging at the UIHC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor

Drugs mentioned

• Ga-68-DOTATOC (Gallium-68 DOTATOC)

Snippet

SUPPL AP for GA-68-DOTATOC (EDOTREOTIDE GALLIUM GA-68)